Press Releases June 1, 2026 04:15 PM

Microchip Technology to Present at the B of A Securities Global Technology Conference 2026

Microchip Technology to Present at B of A Securities Global Technology Conference 2026

By Avery Klein
Share
Twitter Reddit Facebook LinkedIn
MCHP

Microchip Technology Incorporated announced it will present at the B of A Securities Global Technology Conference 2026 on June 2, 2026. The presentation will feature CEO Steve Sanghi and CFO Eric Bjornholt and will be webcast live. Microchip is a leading supplier of semiconductor solutions across multiple sectors including industrial, automotive, consumer, aerospace, defense, communications, and computing.

Microchip Technology to Present at the B of A Securities Global Technology Conference 2026
MCHP
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Microchip Technology will present at a major technology conference, delivering insights into its business strategy and outlook.
  • The company provides semiconductor solutions across diverse and critical sectors such as automotive, industrial, aerospace, and communications.
  • The presentation is accessible via live webcast, allowing broad investor and stakeholder access to company updates.

CHANDLER, Ariz., June 01, 2026 (GLOBE NEWSWIRE) -- (NASDAQ:MCHP) – Microchip Technology Incorporated, a leading provider of smart, connected, and secure embedded control solutions, today announced that the Company will present at the B of A Securities Global Technology Conference 2026 on Tuesday, June 2, 2026 at 2:40 p.m. (Pacific Time). Presenting for the Company will be Mr. Steve Sanghi, President, CEO and Chair, and Mr. Eric Bjornholt, Senior Vice President and Chief Financial Officer. A live webcast of the presentation will be made available by B of A, and can be accessed on the Microchip website at www.microchip.com.

Any forward looking statements made during the presentation are qualified in their entirety by the discussion of risks set forth in the Company's Securities and Exchange Commission filings. Copies of SEC filings can be obtained for free at the SEC's website (www.sec.gov) or from commercial document retrieval services.

Microchip Technology Inc. is a broadline supplier of semiconductors committed to making innovative design easier through total system solutions that address critical challenges at the intersection of emerging technologies and durable end markets. Its easy-to-use development tools and comprehensive product portfolio support customers throughout the design process, from concept to completion. Headquartered in Chandler, Arizona, Microchip offers outstanding technical support and delivers solutions across the industrial, automotive, consumer, aerospace and defense, communications and computing markets. For more information, visit the Microchip website at www.microchip.com.

Note: The Microchip name and logo are registered trademarks of Microchip Technology Inc. in the USA and other countries.

INVESTOR RELATIONS CONTACT:
Deborah Wussler ……… (480) 792-7373


Risks

  • Forward-looking statements during the presentation are subject to risks outlined in the company's SEC filings, indicating potential uncertainties in forecasts or projections.
  • Broader semiconductor market fluctuations and sector-specific challenges could impact company performance, reflecting the overall technology and industrial markets.
  • Competitive pressures and rapidly evolving technologies in semiconductor and embedded systems sectors pose ongoing risks to Microchip's market position.

More from Press Releases

onsemi Introduces Industry-First Elite Pairing Studio to Simplify Power Design Jun 8, 2026 Ingredion Announces Recommended All-Cash Acquisition of Tate & Lyle Jun 8, 2026 Rackspace Technology Establishes Regional Headquarters in Riyadh to Accelerate Cloud and AI Growth Jun 8, 2026 WISeKey, The Hashgraph Group and Hedera Launch QAIT Q-Day Security Assessment Platform on the SEALCOIN Quantum Marketplace Jun 8, 2026 Nurix Therapeutics Announces Global Collaboration with Roche to Co-Develop and Co-Commercialize Potential Best-in-Class BTK Degrader Bexobrutideg Across Malignant Hematology, Immunology and Neurology Jun 8, 2026